Results 231 to 239 of about 35,587 (239)

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

Expert Opinion on Investigational Drugs, 2007

exaly  

Nausea, vomiting and cancer treatment

Ca-A Cancer Journal for Clinicians, 1978
exaly  

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Annals of Oncology, 2006
Steven M Grünberg, M S Aapro, S A Tjulandin   +2 more
exaly  

Chemotherapy-Induced Nausea and Vomiting

1999
D. E. Morganstern, P. J. Hesketh
openaire   +1 more source

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

Expert Opinion on Drug Metabolism and Toxicology, 2009

exaly  

Self-Care Activities for the Person with Nausea and Vomiting

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Chemotherapy-Induced Nausea and Vomiting: The Importance of Acute Antiemetic Control

Oncologist, 2003
exaly  

Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

Journal of the Academy of Nutrition and Dietetics
Alex Molassiotis, Megan Crichton
exaly  

Chemotherapy-induced nausea and vomiting.

The American journal of nursing, 1995
openaire   +1 more source